• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
ZHANG Jing. Analysis on research and development of global cardiovascular drugs in the past 6 years[J]. Journal of China Pharmaceutical University, 2018, 49(6): 760-765. DOI: 10.11665/j.issn.1000-5048.20180619
Citation: ZHANG Jing. Analysis on research and development of global cardiovascular drugs in the past 6 years[J]. Journal of China Pharmaceutical University, 2018, 49(6): 760-765. DOI: 10.11665/j.issn.1000-5048.20180619

Analysis on research and development of global cardiovascular drugs in the past 6 years

More Information
  • Through the retrieval of IntegrityTM, the data of 12 906 cardiovascular drugs in the world from April 2012 to April 2018 were analyzed, and the general features of cardiovascular drugs research and development, target, mechanism, patent information and information on the market were summarized for the past 6 years, and the characteristics of cardiovascular drugs in recent years were suggested. This research may provide references for related R&D personnel.
  • [1]
    Zhongrui Pharmaceutical Business School.Analysis of heart diseases in global and China′s drug market[EB/OL].http://www.sohu.com/a/116303528_495747.
    [2]
    TOP10 global cardiovascular drugs[N]. Medicine Economic Reporter,2017-10-30,F04.
    [3]
    The future prospects of cardiovascular drugs are broad,new targets,and new drugs emerge in endlessly[N].Medicine Economic Reporter,2010-09-09.
    [4]
    Guo YS,Guo ZR.Design of multiple targeted drugs[J].Acta Pharm Sin,2009,44(3):276-281.
    [5]
    The modernization of Chinese medicine has made remarkable achievements in the past twenty years[EB/OL].(2017-07-06)[2018-07-01] https://www.sohu.com/a/155049765_390536.

Catalog

    Article views (798) PDF downloads (1540) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return